Introduction
several putative mechanisms by which connexins may participate in regulating cell growth and differentiation that are GJIC-independent [26] [27] [28] [29] . Furthermore, connexins have been shown to regulate a variety of molecules involved in growth and proliferation [30] , tumor angiogenesis [8] , and cell cycle control [31] .
While many studies have examined the role of connexins in regulating cell growth within the primary tumor, far less is known about the role of connexins and gap junctions during the various stages of metastasis. Reports have suggested that connexin expression reduces the likelihood and instances of tumor cell metastasis [32] [33] [34] . Weakly metastatic rat mammary clones were shown to have higher incidences of GJIC and more gap junction plaques than highly metastatic clones [35] . Also quite interesting is the evidence that under the influence of metastasis suppressive proteins such as breast metastasis suppressor-1 (BRMS-1) [34] or tissue inhibitors of MMPs-1 (TIMP-1) [36] , there was decreased metastasis as well as a restoration of connexin content and/or GJIC. Relevant to our study, the expression of BRMS-1 was shown to cause an increase in Cx43 expression in MDA-MB-435 cells [34] . However, other reports have documented that gap junctions form between tumor cells and endothelium [32, 37] and one report has suggested that the expression of Cx26 may facilitate melanoma cell metastasis in vivo [38] . Thus, a relationship between connexin expression and metastatic potential is beginning to emerge but remains controversial owing to the complexity of the multiple stages and environments tumor cells must pass prior to colonizing in a distinct organ. In addition, it is also be coming more clear that different members of the connexin family as well as different tumor cell types may at Pennsylvania State University on February 20, 2013 http://carcin.oxfordjournals.org/ Downloaded from engage different mechanisms to either inhibit or assist the molecular processes needed for cells to metastasize.
In the current study, we used a variant of the human breast tumor cell line, MDA-MB-435, to examine if the expression of functional and GJIC-incompetent species of Cx26 could change cell growth characteristics, migration and invasion potential of the cells and regulate genes important in cancer progression. To this end, MDA-MB-435 cells were engineered to express: 1. functional wild-type Cx26, 2. a GJIC-incompetent variant of Cx26 that is transported to the cell surface, but is GJIC-incompetent, and 3. a Cx26 mutant found in human populations with Vohwinkels syndrome, that resides within the Golgi apparatus and is therefore also non-functional in terms of GJIC.
Materials and Methods
Cell culture: MDA-MB-435 and NRK (Normal rat kidney) cells were cultured in Dulbecco's modified Eagle's high glucose medium obtained from Invitrogen (Burlington, ON) and MDA-MB-231 cells were cultured in RPMI 1640 medium from Sigma-Aldrich (St. Louis, MO). All cell lines were originally obtained from the American Type Culture Collection (Monassas, VA, USA). Cells were maintained at 37°C in an environment of 95% air and 5% CO 2 in the recommended medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin and 2 mM glutamine.
Constructs and retroviral infection:
Generation of AP2 retroviral vectors containing cDNA for Cx43, Cx26, GFP-Cx26 or D66H-GFP were previously described [7, 39, 40] . All four recombinant retroviral vectors, as well as an empty retroviral vector, were transfected into the 293GPG packaging cell line to produce replication-defective virus-containing supernatant, and the retroviral infection of MDA-MB-435 cells was accomplished as described previously [41] . Five cell lines were created: MDA-MB-435 cells expressing a functional Cx26 (Cx26), a GJIC-incompetent GFP-tagged Cx26 (GFP-Cx26), a mutant Cx26 (D66H-GFP), a functional Cx43 (Cx43) and an empty viral vector (v) control. In each case the expression of recombinant connexins exceeded 90% of the cultured cells as revealed by immunofluorescent labeling for connexins or intrinsic GFP fluorescence. The functional status of MDA-MB-435 cells that expressed wild-type Cx26 and GFP-tagged Cx26 was assessed in a previous study through the use of gap junction permeable dyes [8] .
Immunofluorescent labeling and confocal microscopy: Cells were immunolabeled as described previously by Laird et al. (1995) [42] . Antibodies used in this study were counted in 10 random fields with a standard inverted Leica DM IL microscope (Leica Microsystems Canada Inc., Richmond Hill, ON) using a 10 X objective lens. The investigator was blinded to the cell treatments being counted. The experiment was repeated four times, with three internal replicates. Data are expressed as mean +/-standard deviation and parametric analysis was done using an unpaired Student t-test.
All statistical data was calculated using GraphPad Prisim (San Diego, CA).
Cell growth analysis: 2.5x10
4 cells were suspended in 1.0 ml of culture medium and plated in a 6 well dish with an additional 1ml of culture media. Cells were collected and counted at day 3, 5, 7 and 9 after plating. The experiment was repeated three times, with three internal replicates. Data are expressed as mean +/-standard deviation and parametric analysis was done using an unpaired Student t-test. replicates. Data are expressed as mean +/-standard deviation and parametric analysis was done using an unpaired Student t-test.
SDS-PAGE and Western blot:
SDS-PAGE and Western blotting was performed as previously described [42] . The blots were labeled with anti-Cx43 (Sigma-Aldrich)
(1:5000 dilution), rabbit polyclonal anti-Cx26 (Zymed Laboratories Inc., Z-Z8 ( To assess equal protein loading, nitrocellulose membranes were stripped in REblot (Chemicon International, Temecula, CA), or replica gels were probed for GAPDH
(1:10,000) (Cedarlane Laboratories, Hornby, ON, Canada). Immunoblots were scanned and quantified using Kodak Digital Science 2.0 (Eastman Kodak, Rochester, NY). Data are expressed as mean +/-standard deviation and parametric analysis was done using an unpaired Student t-test.
Zymography and reverse zymography: Equal numbers of cells were grown to 80%
confluence, and then incubated with 2 ml of serum free culture media. After 48 hrs, media was collected, centrifuged at 10,000g for 10 mins at 4°C, and the supernatant was assessed for protein concentration using the BCA protein assay. 40-50 µg of protein was diluted in non-reducing sample buffer (0.5 M Tris, pH 6.8, 20% glycerol, 4% SDS, 0.005% bromophenol blue). Zymography was carried out as previously described with the following changes [43, 44] . Equal concentrations of proteins were separated by OH). Upon completion of electrophoresis, gels were washed twice in 2.5% Triton X-100 solution and rinsed in distilled, deionized H 2 O. The gels were incubated for up to 36 h at 37°C in a developing buffer (50 mM Tris, pH 7.4, 0.2 M NaCl, 5 mM CaCl 2 , 0.02% Brij 35). Gels were stained in Coomassie Brilliant Blue (Bio-Rad Laboratories, Hercules, CA) and zymographs were analyzed and quantified for densitometry using Kodak Digital Science 2.0 (Eastman Kodak, Rochester, NY). The experiment was repeated four times. Data are expressed as mean +/-standard deviation and parametric analysis was done using an unpaired Student t-test. Reverse zymography was preformed as described above with a 12% SDS-PAGE where the gel included 1 ml of purified MMP-9
and included a control lane of purified TIMP-1 (Dr. Kevin Leco, UWO, London, ON).
Results

Expression of connexin variants in MDA-MB-435 cells
In order to assess the mechanistic role of connexins in the regulation of cell migration, growth and invasion it was necessary to generate a series of connexinpositive cell lines on a genetically identical background. To that end, we initiated these studies by characterizing the growth and phenotypic properties of a MDA-MB-435 human breast tumor cell line. Surprisingly, these cells were found to be far less aggressive than reported in other studies [16] exhibiting minimal ability to form tumors in nude mice (data not shown) and they exhibited reduced invasive properties when grown on or within matrigel coated filters as compared to other aggressive human breast tumor cell lines like MDA-MB-231 (see Figure 4B ). In addition, while MDA-MB-435 cells have been reported to express both Cx43 and Cx32 [34] we found no evidence for Cx43 protein and only a small sub-population of cells expressed any detectable Cx32 protein.
Nevertheless, this less aggressive "variant" of the MDA-MB-435 cell line was devoid of Cx26, GJIC-deficient and sufficiently migratory and invasive to assess the impact of the over-expression of functional and GJIC-incompetent connexin species. Importantly, these cells were efficient at trafficking over-expressed connexins to the cell surface for the formation of functional gap junctions, properties not exhibited by MDA-MB-231 cells [7] .
Immunolabeling ( Figure 1A MDA-MB-435 cells [8] . The deafness and skin disease-linked Cx26 mutant, D66H-GFP, was localized to the Golgi apparatus as revealed by the co-localization between D66H-GFP and resident Golgi protein, giantin ( Figure 1A , insert, note yellow color). Since the Cx26 antibody used in this study did not bind human Cx26, the D66H-GFP mutant was not detected on the Western blot ( Figure 1B ). Consequently, cell lysates were probed with a second anti-Cx26 antibody to reveal the presence of the GFP-tagged Cx26 and D66H mutant ( Figure 1C ). This study revealed that, although the D66H mutant was expressed in over 90% of the cell population, it was far less abundant than GFP-Cx26 assuming the antibody had equal affinity for both rat and human Cx26. As controls, Cx43 was localized within gap junction plaques in NRK cells ( Figure 1A ) but predominantly found in intracellular structures in MDA-MB-231 cells as previously described ( Figure 1A ) [8] . These results suggest that both TIMP-1 and MMP-9 are regulated by all functional and GJIC-incompetent connexin variants used.
Expression of functional and GJIC-incompetent
Discussion
Connexins as tumor suppressors
The purpose of this study was to elucidate the mechanism(s) by which connexins act as tumor suppressors. In principle there are four basic mechanisms by which connexins may suppress tumor growth: 1. GJIC, 2. functional hemichannels, 3. gap junction enhanced intercellular adhesion, or 4. connexin-dependent modulation of proteins that regulate tumor cell behavior. It is also plausible that two or more of these mechanisms may act in combination depending on the type of tumor resulting in both cell-type and connexin-specific mechanisms of tumor suppression. It is notable that two of these four mechanisms would not necessitate that connexins form functional gap junction channels or hemichannels. This study focuses on Cx26 because it is expressed in the luminal cells of human as well as rodent breast lobules and ducts [5, 45] which are the origin of most breast tissue carcinomas. Importantly, Cx26 was identified as a tumor suppressor in both rodent and human breast tumors and cell lines [7, [13] [14] [15] [16] . Thus, the purpose of this study was to engineer and employ a series of cell lines which would allow for the investigation of the mechanism by which Cx26 may act to suppress the tumorigenic phenotypes of human breast cancer cells. A less aggressive variant of the connexin-deficient human breast tumor cell line, MDA-MB-435, was chosen as a platform to re-introduce functional and GJIC-incompetent variants of
Cx26.
GJIC appears unnecessary for Cx26-based growth control
It has already been established that connexins exert an inhibitory effect on tumor growth when re-introduced in breast tumor cells, however the properties of Cx26 that are required to exert this effect have remained elusive. Our studies revealed that the cell surface expression of a GJIC-incompetent variant of Cx26 (GFP-Cx26) possessed a similar ability as functional Cx26 to inhibit in vitro growth of MDA-MB-435 cells in the absence of any contribution to GJIC or functional hemichannel formation [8, 46, 47] . With increasing evidence of cross-talk between gap and adherens junctions [25] , one possibility is that cell surface Cx26 contributes to the overall adhesive properties between adjacent cells. Cell adhesion is thought to be required for the assembly of gap junctions at the cell surface [48] . Conversely, blocking gap junction assembly has been shown to inhibit the formation of adherens junctions in rat hepatoma cells [19] . It has also been suggested that connexins may interact with other junctional complexes to regulate overall cell adhesion and intercellular junction formation [49] . A GJICindependent but connexin-dependent pathway for regulating cell growth has gained increasing merit as several studies support this possibility [7, [26] [27] [28] [29] . Since the mere expression of Cx26 alone in the form of the D66H-GFP mutant did not reduce MDA-MB-435 cell growth this would suggest that the cell surface expression of Cx26 may be a critical necessity. While such a conclusion would seem reasonable some caution should be exercised before reaching such a position. For instance, even though the D66H mutant was expressed in the vast majority of cells the overall expression level was significantly less compared to either Cx26 or GFP-Cx26 thus leaving the possibility that at high levels the D66H mutant may also reduce cell growth. Moreover, our studies revealed that Cx43 can readily assemble gap junction plaques but failed to reduce MDA-MB-435 cell growth further suggesting that the mere delivery of "any" connexin is not sufficient to induce growth control.
Cx26 inhibits migration and invasion independent of its cell surface transport and assembly into functional gap junctions.
In our study we present evidence that the functional status or subcellular localization of Cx26 appears to be of minimal significance for Cx26 to inhibit MDA-MB-435 cell migration and invasion or to regulate genes important in these processes. In this regard, all over-expressed Cx26 variants exhibited the ability to significantly inhibit the migration of MDA-MB-435 cells. At this stage it is impossible to determine if they regulate migration by identical mechanisms and given that the D66H mutant has a steady-state profile that reflects its localization to the Golgi apparatus [40] , it is possible that the bolus of mutant protein may act to indirectly affect the secretion of proteins important in migration. Given the immense capability of cells to secrete, this seems unlikely but all protein over-expression strategies remain subject to such critique. It is also difficult to completely eliminate the possibly that Cx26 variant over-expression may up-regulate other compensatory connexins family members in these MDA-MB-435 cells.
However, we have previously showed that Lucifer yellow failed to transfer between MDA-MB-435 cells that over-expressed GFP-Cx26 [8] . It is notable that the D66H mutant caused a non-statistically significant trend toward a reduction in cell invasion. At first approximation this could suggest that it is a far less potent mutant (or even incompetent) at inhibiting cell invasion but this may also reflect the fact that it is expressed at lower levels than either Cx26 or GFP-Cx26. It is also important to note that we examined the migratory or invasive properties of cells that have disrupted their junctional contact with neighboring cells prior to movement through the pores of uncoated or matrix coated filters. Given the well understood principle that tumor cell lines are typically heterogeneous, it is possible that cells that retain junctional contact with their neighbors, represent a second population that are more resistant to Cx26-induced changes in cell migratory and invasive properties.
In culture, MDA-MB-435 cells exhibited characteristics of integrin-induced, actindependent cytoskeletal remodeling [50, 51] and cell spreading as evidenced by prominent stress fibers. Cells expressing functional, GJIC-incompetent, and mutant
Cx26 appeared more compact with actin staining being mainly perinuclear. In prostate cells, drug inhibition of Cx26-based GJIC was found to inhibit invasion and migratory properties of PC-3 cells, and furthermore, evidence was presented for a direct interaction between Cx26 and focal adhesion kinase [52] . This study would argue for a link between Cx26 and focal contacts through a mechanism that may not require Cx26
to be functional in cell-cell communication. Moreover, other studies have shown that interactions with the extracellular matrix induce GJIC and promote mammary epithelial cell differentiation [53] . Interestingly, a recent study demonstrated a potential role for β1-integrin in the development of breast cancer in conditional transgenic mouse model [54] .
In our study, Western blot analysis revealed that the expression of functional, GJICincompetent and mutant Cx26, as well as Cx43, down-regulated β1 integrin levels by 2-3 fold. Hence, the Cx26-induced cytoskeletal rearrangement and reduction in β1 integrin expression seen in MDA-MB-435 cells may be part of the molecular mechanism responsible for the phenotypic change in cell migration. However, since Cx43 expression also induced a down-regulation of β1 integrin with only a minimal effect on cell migration and invasion, the mechanism must be more complex and extend beyond β1 integrin regulation.
MMP-9, an enzyme involved in extracellular matrix degradation [55] and a direct substrate of TIMP-1 [56] , was found to have lower activity levels in all Cx26 and Cx26 . It is also notable that some connexins are poor tumor suppressors in vitro but potent inhibitors of tumor cell growth in vivo [7] .
How does GJIC-incompetent Cx26 signal to regulate gene expression levels?
Mechanistically, it would seem plausible that Cx26 and its' GJIC-incompetent variants regulate cell proliferation, migration and invasion by putative binding partners.
It has already been established that more then one member of the connexin family of proteins interacts with ZO-1, ZO-2, Src, tubulin and several protein kinases [24] [25].
However, only an ubiquitin ligase subunit, OCP1, found in the organ of Corti [60] and focal adhesion kinase [52] have been reported to interact with Cx26. Cx26 has a relatively short polypeptide domains exposed to the cytoplasm and lacks any nuclear localization sequences. Thus, it is most unlikely that any Cx26 proteolytic fragment or intact molecules extracted from the membrane would signal directly to the nucleus.
Given the surge of new connexin binding partners being identified it is likely that additional Cx26-associated signaling molecules will be identified in the near future that may shed some insight into how Cx26 is linked to tumor growth, progression and metastasis.
In summary, these data indicate that Cx26 plays a pivotal role in reducing the tumorigenicity of a non-aggressive variant of the MDA-MB-435 breast tumor cell line.
Cx26-induced tumor suppression relies on a unique GJIC-independent mechanism, although it still remains possible that GJIC will augment the tumor suppressive effect or that GJIC will play a more central role in other cell types. Interestingly, the over- (**p<0.005, *** p<0.001). Gelatin zymography of cultured media collected from WT cells and cells expressing the empty vector (v), or cells expressing Cx26, GFP-Cx26, D66H-GFP or Cx43 was used to assess changes in MMP-9 activity (A). Although, proMMP-9 (92kDa) and active MMP-9
(84kDa) were detected in all cells, a decrease in MMP-9 activity was seen in cells expressing Cx26, GFP-Cx26, D66H-GFP or Cx43 (C) (n=4). Reverse gelatin zymography of the same cultured media, was completed in order to determine if there was an increase in TIMP-1 activity in connexin-expressing cells. Increased TIMP-1 (migrating at 28kDa) activity (note the reduction in band intensity within the red box
